MedTrace Logo

Dietary Supplementation on Body Fat Composition

NCT06296251 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2024-05-16

No results posted yet for this study

Summary

The purpose of the current study is to examine the effects of a dietary supplement containing plant derived phenolics at two different dose levels in otherwise generally healthy adults with risk factors (high BMI at dyslipidemia and/or pre-diabetes) for body fat composition. The primary hypothesis is that supplementation with plant derived phenolics will decrease body fat composition compared to placebo.

Conditions

  • Dyslipidemias
  • Pre-diabetes

Interventions

OTHER

Placebo treatment

Microcrystaline cellulose (MCC)

DIETARY_SUPPLEMENT

Plant derived phenolics

Dietary supplement containing plant derived phenolics

Sponsors & Collaborators

  • Brightseed

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-04-18
Primary Completion
2024-12-27
Completion
2025-02-27

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06296251 on ClinicalTrials.gov